Crossmark Global Holdings Inc. Purchases Shares of 7,791 Ingevity Corporation (NGVT)
Crossmark Global Holdings Inc. purchased a new stake in Ingevity Corporation (NYSE:NGVT) in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund purchased 7,791 shares of the company’s stock, valued at approximately $487,000.
A number of other institutional investors and hedge funds also recently bought and sold shares of the business. Pacad Investment Ltd. bought a new stake in shares of Ingevity Corporation during the second quarter worth about $183,000. Flagship Harbor Advisors LLC bought a new stake in shares of Ingevity Corporation during the third quarter worth about $216,000. Cubist Systematic Strategies LLC bought a new stake in shares of Ingevity Corporation during the second quarter worth about $203,000. Balyasny Asset Management LLC bought a new stake in shares of Ingevity Corporation during the second quarter worth about $213,000. Finally, Los Angeles Capital Management & Equity Research Inc. increased its position in shares of Ingevity Corporation by 5.4% during the second quarter. Los Angeles Capital Management & Equity Research Inc. now owns 4,072 shares of the company’s stock worth $234,000 after acquiring an additional 210 shares in the last quarter. 90.84% of the stock is owned by hedge funds and other institutional investors.
Several research firms have recently commented on NGVT. Loop Capital reissued a “buy” rating and set a $80.00 target price (up from $76.00) on shares of Ingevity Corporation in a research report on Tuesday, November 14th. Zacks Investment Research raised shares of Ingevity Corporation from a “sell” rating to a “hold” rating in a research report on Tuesday, August 8th. BidaskClub raised shares of Ingevity Corporation from a “sell” rating to a “hold” rating in a research report on Thursday, October 12th. KeyCorp reissued a “buy” rating and set a $75.00 target price (up from $70.00) on shares of Ingevity Corporation in a research report on Thursday, October 5th. Finally, Jefferies Group LLC boosted their target price on shares of Ingevity Corporation from $71.00 to $84.00 and gave the stock a “buy” rating in a research report on Friday, November 3rd. Seven equities research analysts have rated the stock with a buy rating, The company has an average rating of “Buy” and an average price target of $73.17.
Shares of Ingevity Corporation (NYSE NGVT) opened at $73.32 on Monday. The company has a current ratio of 2.36, a quick ratio of 1.34 and a debt-to-equity ratio of 1.92. The company has a market cap of $3,087.91, a PE ratio of 29.68, a PEG ratio of 2.45 and a beta of 1.66. Ingevity Corporation has a 52-week low of $48.74 and a 52-week high of $76.00.
Ingevity Corporation (NYSE:NGVT) last released its quarterly earnings results on Wednesday, November 1st. The company reported $0.86 earnings per share for the quarter, topping the consensus estimate of $0.75 by $0.11. Ingevity Corporation had a net margin of 9.86% and a return on equity of 58.14%. The business had revenue of $264.10 million for the quarter, compared to analysts’ expectations of $260.88 million. During the same period in the previous year, the company earned $0.64 earnings per share. The firm’s revenue for the quarter was up 4.6% compared to the same quarter last year. research analysts anticipate that Ingevity Corporation will post 2.49 EPS for the current year.
Ingevity Corporation Company Profile
Ingevity Corporation is a manufacturer of specialty chemicals and high performance carbon materials. The Company is also a manufacturer of activated carbon used in gasoline vapor emission control systems in cars, trucks, motorcycles and boats. The Company operates through two segments: Performance Materials and Performance Chemicals.
Want to see what other hedge funds are holding NGVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ingevity Corporation (NYSE:NGVT).
Receive News & Stock Ratings for Ingevity Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity Corporation and related stocks with our FREE daily email newsletter.